The role of FcgammaRIIA and IIIA polymorphisms in autoimmune diseases.
about
Alloantibody Generation and Effector Function Following Sensitization to Human Leukocyte AntigenCD16 and CD32 Gene Polymorphisms May Contribute to Risk of Idiopathic Thrombocytopenic Purpura.Heparin-induced thrombocytopenia: the role of platelets genetic polymorphisms.The genetics and epigenetics of autoimmune diseases.Fcγ receptor IIIa single-nucleotide polymorphisms and haplotypes affect human IgG binding and are associated with lupus nephritis in African AmericansFCGR2C polymorphisms associate with HIV-1 vaccine protection in RV144 trial.Genetic associations in type I interferon related pathways with autoimmunityA pooled analysis of three studies evaluating genetic variation in innate immunity genes and non-Hodgkin lymphoma risk.Association of Fcγ receptor IIIa genotype with the rate of HIV infection after gp120 vaccinationCurrent status of lupus geneticsGenetic variation in C-reactive protein (CRP) gene may be associated with risk of systemic lupus erythematosus and CRP concentrationsTargeting of the immune system in systemic lupus erythematosus.Polymorphism of the Fcgamma receptor IIA and malaria morbidity.Recapitulation of Candidate Systemic Lupus Erythematosus-Associated Variants in Koreans.Genetic studies of systemic lupus erythematosus in Asia: where are we now?The Role and Function of Fcγ Receptors on Myeloid Cells.Antibody Functional Assays as Measures of Fc Receptor-Mediated Immunity to HIV - New Technologies and their Impact on the HIV Vaccine Field.Signaling by Antibodies: Recent Progress.Ethnic variation of Fc gamma receptor polymorphism in Sami and Norwegian populations.Correlation of Fc-γ RIIA polymorphisms with latent Epstein-Barr virus infection and latent membrane protein 1 expression in patients with low grade B-cell lymphomas.No association of primary Sjögren's syndrome with Fcγ receptor gene variants.Association of FcgR2a, but not FcgR3a, with inflammatory bowel diseases across three Caucasian populations†
P2860
Q26766411-125E0FF1-1A80-4474-954C-8A4C5C12529FQ30249541-0357C888-BC25-41C6-B086-437462A853F3Q33402336-2BEC533C-86ED-4182-ADE3-BA1678B1E1B2Q33642586-1FE52F27-B883-4B13-B1A5-F8AAE0738F15Q33800921-54C93BF8-3479-4B5F-B81D-849B6680ED58Q34117524-06470049-6D3B-4C5A-AE8B-A8ED02CDFF45Q34350182-624BC49B-1B51-45A2-9ACE-E09F4B7B9F0AQ35660939-6F21F6C5-D7EA-499F-8F6F-3CE6C4978CB9Q36305326-BCE9D245-B456-40B5-9B43-50908B3FF99FQ36392330-0F85E1D1-812C-42E5-AAE5-85D2577CBA93Q36972054-2E6E7B57-8864-4F25-B2AE-875E5EA410D5Q37060593-8393702C-8FD0-442B-B8E2-D5ED3BE32D65Q37241860-232BA2D3-E2D7-47C3-A92F-0D22F4E19A51Q37324845-F39C107E-C4ED-401F-8B55-98700E7C5DACQ37439346-7664632B-FF66-4898-A27C-B922E5D77445Q39088502-813B2D9B-22CD-4084-BA21-F5F012D8E9D2Q39189458-CA6EB460-6892-4BA5-AB59-49E31D676EA2Q39264890-B4B7312C-D6E8-4F1B-A271-164037BF5791Q45305556-2AB53BE6-BBD9-4F43-BE50-C065BFD0FED7Q45353312-E74CC73F-9D1D-4829-BA52-CB2E1CAF2005Q46093255-9056DA10-11D5-4CFE-8A57-23F9F913BC3DQ56968637-64E440B2-2AE3-460A-9E24-CE8608B62D5F
P2860
The role of FcgammaRIIA and IIIA polymorphisms in autoimmune diseases.
description
2004 nî lūn-bûn
@nan
2004 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
The role of FcgammaRIIA and IIIA polymorphisms in autoimmune diseases.
@ast
The role of FcgammaRIIA and IIIA polymorphisms in autoimmune diseases.
@en
type
label
The role of FcgammaRIIA and IIIA polymorphisms in autoimmune diseases.
@ast
The role of FcgammaRIIA and IIIA polymorphisms in autoimmune diseases.
@en
prefLabel
The role of FcgammaRIIA and IIIA polymorphisms in autoimmune diseases.
@ast
The role of FcgammaRIIA and IIIA polymorphisms in autoimmune diseases.
@en
P1476
The role of FcgammaRIIA and IIIA polymorphisms in autoimmune diseases.
@en
P2093
Fotini B Karassa
Thomas A Trikalinos
P304
P356
10.1016/J.BIOPHA.2004.04.004
P577
2004-06-01T00:00:00Z